EP 0981538 A1 20000301 - PHARMACEUTICALLY ACCEPTABLE SALTS OF 5ALPHA-PREGNAN-3BETA, 16ALP HA-DIOL-20-ONE 3-SULFATE USEFUL AS PROGESTINS AND CNS DISORDERS
Title (en)
PHARMACEUTICALLY ACCEPTABLE SALTS OF 5ALPHA-PREGNAN-3BETA, 16ALP HA-DIOL-20-ONE 3-SULFATE USEFUL AS PROGESTINS AND CNS DISORDERS
Title (de)
PHARMAZEUTISCHE ANWENDBARE SÄLZE VON 5.ALPHA.-PREGNAN-3.BETA.,16.ALPHA.-DIOL-20-ON 3-SULPHAT ZUR BEHANDLUNG VON ZNS KRANKHEITEN UND ZUR GESTAGENTHERAPIE
Title (fr)
SELS PHARMACEUTIQUEMENT ACCEPTABLES DE 5ALPHA-PREGNAN-3BETA, 16ALPHA-DIOL-20-ONE 3-SULFATE UTILISES COMME PROGESTATIFS ET DANS LES TROUBLES DU SNC
Publication
Application
Priority
- US 9808454 W 19980428
- US 85057197 A 19970502
Abstract (en)
[origin: WO9850411A1] The invention provides a pharmaceutically acceptable salt of 5 alpha -pregnan-3 beta , 16 alpha -diol-20-one 3-sulfate ester, which is useful as a progestational agent.
IPC 1-7
IPC 8 full level
A61K 31/57 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07J 31/00 (2006.01)
CPC (source: EP KR)
A61P 25/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07J 31/00 (2013.01 - KR); C07J 31/006 (2013.01 - EP)
Citation (search report)
See references of WO 9850411A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9850411 A1 19981112; AR 012637 A1 20001108; AU 7164598 A 19981127; AU 746326 B2 20020418; BR 9809435 A 20000613; CA 2289096 A1 19981112; CN 1254342 A 20000524; EP 0981538 A1 20000301; JP 2001527552 A 20011225; KR 20010012180 A 20010215; ZA 983706 B 19991101
DOCDB simple family (application)
US 9808454 W 19980428; AR P980102023 A 19980430; AU 7164598 A 19980428; BR 9809435 A 19980428; CA 2289096 A 19980428; CN 98804764 A 19980428; EP 98918787 A 19980428; JP 54815398 A 19980428; KR 19997010129 A 19980428; ZA 983706 A 19980430